Imris, Deerfield Imaging
Private Company
Total funding raised: $50M
Overview
IMRIS is a pioneering commercial-stage company in the intraoperative imaging market, offering a unique, mobile high-field MRI solution for neurosurgical suites. Its InVision Operating Suite integrates advanced imaging directly into the surgical workflow, allowing neurosurgeons to obtain real-time MRI scans without moving the patient, thereby enhancing precision, safety, and confidence during brain surgery. The company operates on a capital equipment and comprehensive service model, generating revenue from the sale and installation of its complex systems and long-term clinical support. With an estimated 70,000+ patients treated globally using its technology, IMRIS has established itself as a leader in image-guided therapy for neurosurgery.
Technology Platform
Ceiling-mounted rail transport system for moving high-field (1.5T/3T) MRI magnets between operating rooms and a diagnostic suite, enabling real-time intraoperative imaging without patient movement.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
IMRIS competes in the high-end intraoperative MRI market against providers of fixed high-field iMRI suites (e.g., Siemens, GE) and lower-field, in-room MRI systems (e.g., Medtronic, Hitachi). Its primary differentiation is the moving magnet system, which offers diagnostic-quality imaging without moving the patient, a unique value proposition for high-volume neurosurgical centers.